Workflow
CDK7 Therapeutics
icon
Search documents
Recursion Pharmaceuticals (NasdaqGS:RXRX) 2025 Conference Transcript
2025-11-18 11:32
Recursion Pharmaceuticals (NasdaqGS:RXRX) 2025 Conference November 18, 2025 05:30 AM ET Company ParticipantsChris Gibson - Co-Founder and CEONajat Khan - Chief R and D Officer and Chief Commercial OfficerConference Call ParticipantsDennis Ting - Biotech AnalystDennis TingMorning. Welcome to the Jefferies London Healthcare Conference. My name is Dennis Ting, biotech analyst here at Jefferies. I have the wonderful pleasure of having Recursion Pharmaceuticals up here with us. We have Chris Gibson and also Naja ...